Total Funding
1
44
Total FundingVenture - Series Unknown raised
Growth Score
-4 pts
Heat Score
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
68399
Vapogenix is a clinical stage company developing a new class of non-narcotic analgesics for localized pain.
Clarice Motter: Chief Financial Officer
Heather Giles: CEO, Chief Scientific Officer, Director, President
About the Company
Vapogenix is a clinical-stage company developing a new class of non-narcotic analgesics for localized pain. It focuses on treating pain locally at its source their products are formulated volatile anesthetics currently unformulated volatile anesthetics are used only as general anesthetics, by inhalation.
It was founded in 2006 and headquartered
in Houston, Texas.
Women Founded
Women Led
